Substrate characterization and catheter ablation for monomorphic ventricular tachycardia in patients with apical hypertrophic cardiomyopathy

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 1, 2011, Pages 41-48

  Inada, Keiichi ^a   Seiler, Jens ^a   Roberts Thomson, Kurt C ^a   Steven, Daniel ^a   Rosman, Jonathan ^a   John, Roy M ^a   Sobieszczyk, Piotr ^a   Stevenson, William G ^a   Tedrow, Usha B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

apical hypertrophic cardiomyopathy; catheter ablation; epicardial ablation; transcoronary ethanol ablation; ventricular tachycardia

Indexed keywords

AMIODARONE; LIDOCAINE; METOPROLOL; SOTALOL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CATHETER ABLATION; EPICARDIUM; FEMALE; HEART ANEURYSM; HEART HYPERTROPHY; HEART RIGHT VENTRICLE OUTFLOW TRACT; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; QRS COMPLEX; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; BODY SURFACE POTENTIAL MAPPING; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 78751497777     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2010.01875.x     Document Type: Article

References (27)

1. Eriksson MJ, Sonnenberg B, Woo A, Rakowski P, Parker TG, Wigle ED, Rakowski H,: Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39: 638-645.
2. Ridjab D, Koch M, Zabel M, Schultheiss HP, Morguet AJ,: Cardiac arrest and ventricular tachycardia in Japanese-type apical hypertrophic cardiomyopathy. Cardiology 2007; 107: 81-86.
3. Okishige K, Sasano T, Yano K, Azegami K, Suzuki K, Itoh K,: Serious arrhythmias in patients with apical hypertrophic cardiomyopathy. Intern Med 2001; 40: 396-402.
4. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, Favale S, Rea RF, Boriani G, Estes NA III, Spirito P,: Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 365-373.
5. Mantica M, Della Bella P, Arena V,: Hypertrophic cardiomyopathy with apical aneurysm: A case of catheter and surgical therapy of sustained monomorphic ventricular tachycardia. Heart 1997; 77: 481-483.
6. Rodriguez LM, Smeets JL, Timmermans C, Blommaert D, van Dantzig JM, de Muinck EB, Wellens HJ,: Radiofrequency catheter ablation of sustained monomorphic ventricular tachycardia in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol 1997; 8: 803-806.
7. Okumura Y, Watanabe I, Ohkubo K, Saito S,: Successful catheter ablation for incessant ventricular tachycardia in a patient with hypertrophic cardiomyopathy. Circ J 2007; 71: 1164-1168.
8. Lim KK, Maron BJ, Knight BP,: Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm. J Cardiovasc Electrophysiol 2009; 20: 445-447.
9. Choi EY, Rim SJ, Ha JW, Kim YJ, Lee SC, Kang DH, Park SW, Song JK, Sohn DW, Chung N,: Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: Multicenter echo-Doppler study. Cardiology 2008; 110: 53-61.
10. Stevenson WG, Friedman PL, Kocovic D, Sager PT, Saxon LA, Pavri B,: Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998; 98: 308-314.
11. Soejima K, Suzuki M, Maisel WH, Brunckhorst CB, Delacretaz E, Blier L, Tung S, Khan H, Stevenson WG,: Catheter ablation in patients with multiple and unstable ventricular tachycardias after myocardial infarction: Short ablation lines guided by reentry circuit isthmuses and sinus rhythm mapping. Circulation 2001; 104: 664-669.
12. Brunckhorst CB, Delacretaz E, Soejima K, Maisel WH, Friedman PL, Stevenson WG,: Identification of the ventricular tachycardia isthmus after infarction by pace mapping. Circulation 2004; 110: 652-659.
13. Sosa E, Scanavacca M, d'Avila A, Oliveira F, Ramires JA,: Nonsurgical transthoracic epicardial catheter ablation to treat recurrent ventricular tachycardia occurring late after myocardial infarction. J Am Coll Cardiol 2000; 35: 1442-1449.
14. Sacher F, Sobieszczyk P, Tedrow U, Eisenhauer AC, Field ME, Selwyn A, Raymond JM, Koplan B, Epstein LM, Stevenson WG,: Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era. Heart Rhythm 2008; 5: 62-68.
15. Bazan V, Gerstenfeld EP, Garcia FC, Bala R, Rivas N, Dixit S, Zado E, Callans DJ, Marchlinski FE,: Site-specific twelve-lead ECG features to identify an epicardial origin for left ventricular tachycardia in the absence of myocardial infarction. Heart Rhythm 2007; 4: 1403-1410.
16. Berruezo A, Mont L, Nava S, Chueca E, Bartholomay E, Brugada J,: Electrocardiographic recognition of the epicardial origin of ventricular tachycardias. Circulation 2004; 109: 1842-1847.
17. Daniels DV, Lu YY, Morton JB, Santucci PA, Akar JG, Green A, Wilber DJ,: Idiopathic epicardial left ventricular tachycardia originating remote from the sinus of valsalva: Electrophysiological characteristics, catheter ablation, and identification from the 12-lead electrocardiogram. Circulation 2006; 113: 1659-1666.
18. Waldo AL, Plumb VJ, Arciniegas JG, MacLean WA, Cooper TB, Priest MF, James TN,: Transient entrainment and interruption of the atrioventricular bypass pathway type of paroxysmal atrial tachycardia. A model for understanding and identifying reentrant arrhythmias. Circulation 1983; 67: 73-83.
19. Stevenson WG, Khan H, Sager P, Saxon LA, Middlekauff HR, Natterson PD, Wiener I,: Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993; 88 (4 Pt 1): 1647-1670.
20. Ito S, Tada H, Naito S, Kurosaki K, Ueda M, Hoshizaki H, Miyamori I, Oshima S, Taniguchi K, Nogami A,: Development and validation of an ECG algorithm for identifying the optimal ablation site for idiopathic ventricular outflow tract tachycardia. J Cardiovasc Electrophysiol 2003; 14: 1280-1286.
21. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C,: Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 1986; 55: 575-581.
22. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS, Epstein AE, Almquist AK, Daubert JP, Lawrenz T, Boriani G, Estes NA III, Favale S, Piccininno M, Winters SL, Santini M, Betocchi S, Arribas F, Sherrid MV, Buja G, Semsarian C, Bruzzi P,: Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 2007; 298: 405-412. (Pubitemid 47124061)
23. Alfonso F, Frenneaux MP, McKenna WJ,: Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: Association with left ventricular apical aneurysm. Br Heart J 1989; 61: 178-181.
24. Furushima H, Chinushi M, Iijima K, Sanada A, Izumi D, Hosaka Y, Aizawa Y,: Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: Incidence, prognosis, and relation to type of hypertrophy. J Cardiovasc Electrophysiol: DOI:.
25. Morimoto S, Sekiguchi M, Uemura A, Hiramitsu S, Kimura K, Ohtsuki M, Ishii J, Kato S, Kasanuki H, Hishida H,: Cardiac muscle cell disorganization in apical hypertrophic cardiomyopathy: A cardiac biopsy study. Jpn Heart J 2003; 44: 505-513.
26. Varnava AM, Elliott PM, Mahon N, Davies MJ, McKenna WJ,: Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001; 88: 275-279.
27. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, Kuhn HJ,: Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999; 20: 1342-1354.